Insulet teams up with Calm to launch The Mind in Range Collection, offering mindfulness and sleep support to help people living with diabetes manage emotional wellbeing alongside glucose control, signalling a shift towards holistic disease management.
Insulet has teamed up with Calm to add mindfulness and sleep support to the diabetes care toolkit, in a move that underscores how closely emotional wellbeing and glucose management are linked. The companies said the free collection is aimed at people living with diabetes, their carers and healthcare professionals, and is intended to address the stress, anxiety, sleep disruption and burnout that can accompany day-to-day care.
The initiative, called The Mind in Range Collection, brings together short guided meditations, a breathing exercise and a Calm Sleep Story narrated by Lila Moss, a fashion model and Omnipod user who lives with type 1 diabetes. According to Insulet, the content is available through Calm’s website and its Calm and Calm Sleep apps, and will be promoted globally through both companies’ platforms over the course of the year. Calm said the deal is its first integrated content partnership with a medical technology company.
Insulet said research it commissioned found strong demand for support that extends beyond devices and clinical targets. It said 62% of people with type 1 diabetes and 60% of those with type 2 diabetes wanted help that included mental health and mindfulness, while 66% of people with diabetes and 46% of carers reported poor sleep linked to diabetes-related stress and anxiety. The company also pointed to global data suggesting that nearly four in five people with diabetes experience burnout from managing the condition.
The collaboration reflects a broader push in diabetes care towards more holistic support, with companies and advocates increasingly framing mental health as part of routine disease management rather than an optional extra. Insulet chief growth officer Manoj Raghunandanan said the partnership recognises the emotional side of diabetes and broadens support beyond physical outcomes, while Calm chief clinical officer Dr Chris Mosunic said the aim is to ease some of the mental strain associated with the condition.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
